Because the interaction of RBD of SARS-CoV-2 S-protein and ACE2 receptor is very important for the entry of virus into the host cells during infection, thus bioactive compound of Withania somnifera such as withanone and withaferin-A may be implicated for the management and treatment of COVID-19 (CMP, 2020). The gene discussed is PROS1; the disease is infection.